0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.39%
Negative revenue growth while 0455.HK stands at 100.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.05%
Negative gross profit growth while 0455.HK is at 100.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
-49.95%
Negative operating income growth while 0455.HK is at 100.00%. Joel Greenblatt would press for urgent turnaround measures.
-11.57%
Negative net income growth while 0455.HK stands at 100.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-10.80%
Negative EPS growth while 0455.HK is at 100.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.80%
Negative diluted EPS growth while 0455.HK is at 100.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.83%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.83%
Reduced diluted shares while 0455.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-125.46%
Negative OCF growth while 0455.HK is at 305.53%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-125.55%
Negative FCF growth while 0455.HK is at 93.51%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-64.23%
Negative 10Y revenue/share CAGR while 0455.HK stands at 701.27%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-63.34%
Negative 5Y CAGR while 0455.HK stands at 586.59%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-63.63%
Negative 3Y CAGR while 0455.HK stands at 459.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-231.27%
Negative 10Y OCF/share CAGR while 0455.HK stands at 339.83%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-246.17%
Negative 5Y OCF/share CAGR while 0455.HK is at 513.73%. Joel Greenblatt would question the firm’s operational model or cost structure.
49.50%
3Y OCF/share CAGR under 50% of 0455.HK's 928.51%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-77.53%
Negative 10Y net income/share CAGR while 0455.HK is at 64.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-41.50%
Negative 5Y net income/share CAGR while 0455.HK is 150.79%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-51.85%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
2.52%
Positive 5Y equity/share CAGR while 0455.HK is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-1.93%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
-51.20%
Negative 5Y dividend/share CAGR while 0455.HK stands at 545.09%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-15.61%
Negative near-term dividend growth while 0455.HK invests at 362.80%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
2.61%
AR growth of 2.61% while 0455.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-13.49%
Inventory is declining while 0455.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-11.95%
Negative asset growth while 0455.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.49%
BV/share growth above 1.5x 0455.HK's 0.16%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-60.19%
We’re deleveraging while 0455.HK stands at 363.98%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0455.HK invests at 100.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-18.87%
We cut SG&A while 0455.HK invests at 100.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.